Cabaletta Bio Inc. (CABA) Statistics & Valuation Metrics - Stocknear

Cabaletta Bio Inc.

NASDAQ: CABA · Real-Time Price · USD
1.70
0.16 (10.39%)
At close: Sep 05, 2025, 3:59 PM
1.72
1.11%
After-hours: Sep 05, 2025, 07:55 PM EDT

Cabaletta Bio Statistics

Share Statistics

Cabaletta Bio has 91.47M shares outstanding. The number of shares has increased by 84.13% in one year.

91.47M
84.13%
84.02%
72.57%
79.01M
597
0.03%

Short Selling Information

The latest short interest is 6.31M, so 6.9% of the outstanding shares have been sold short.

6.31M
6.9%
7.02%
3.98

Valuation Ratios

The PE ratio is -0.97 and the forward PE ratio is -0.87. Cabaletta Bio's PEG ratio is -0.02.

-0.97
-0.87
0
62.2
0.74
-1.24
-0.02
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Cabaletta Bio.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 6.15, with a Debt / Equity ratio of 0.1.

6.15
6.15
0.1
-0.12
-0.17
-167.3

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-719.65K
161
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -60.09% in the last 52 weeks. The beta is 2.85, so Cabaletta Bio's price volatility has been higher than the market average.

2.85
-60.09%
1.58
1.92
57.99
1,830,072

Income Statement

n/a
-4.81M
-125.14M
-115.86M
-125.14M
-116.61M
-2.34
Full Income Statement

Balance Sheet

The company has 163.96M in cash and 15.6M in debt, giving a net cash position of 148.36M.

163.96M
15.6M
148.36M
-349.1M
224.5M
156.87M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -88.22M and capital expenditures -2.21M, giving a free cash flow of -90.43M.

-88.22M
-2.21M
-90.43M
-1.83
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

CABA does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for CABA is $12.5, which is 635.3% higher than the current price. The consensus rating is "Buy".

$12.5
635.3%
Buy
8
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-2.16
1